Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares.

| More on:
a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With most brokers taking a break over the holiday period, research notes are few and far between right now.

But don't worry! Listed below are three recent broker buy recommendations that still have plenty of upside potential.

Here's why brokers think these ASX shares are in the buy zone:

Pilbara Minerals Ltd (ASX: PLS)

According to a note from Bell Potter, its analysts upgraded this lithium miner's shares to a buy rating with a $2.95 price target.

The broker made the move for a couple of key reasons. The first was on valuation grounds believing that a sharp pullback in its share price has created a buying opportunity for investors. Especially now that short interest in the lithium miner is falling.

Another key reason to invest, according to Bell Potter, is the improving outlook for lithium. Its analysts believe that there could be lithium supply deficits from 2026, which would be a huge boost to prices.

And with Pilbara Minerals having a very strong balance sheet, Bell Potter feels that it is well-placed to respond. The Pilbara Minerals share price is trading at $2.24 this morning.

Pro Medicus Limited (ASX: PME)

A note from Goldman Sachs revealed that its analysts retained their buy rating on this health imaging technology company's shares with an improved price target of $278.00.

The broker believes that Pro Medicus is one of Australia's best global growth companies. This is based partly on its belief that further Visage 7 adoption is a matter of when not if. Goldman is forecasting a strong increase in the value and cadence of contract wins over time.

And while it acknowledges that Pro Medicus' shares are not cheap, trading on 114x FY26E EV/EBITDA, the broker feels that this premium is justified due to its revenue/margin outlook, unique cloud offering, and significant long-term opportunity. The Pro Medicus share price is fetching $250.14 on Friday.

Super Retail Group Ltd (ASX: SUL)

Analysts at Morgans retained their add rating on this retail group's shares with a trimmed price target of $18.55. This followed the release of a first-quarter update from the BCF, Rebel, Macpac, and Supercheap Auto owner.

Morgans notes that the update was a touch softer than expected. This has led to its analysts trimming their earnings forecasts to reflect the challenging trading conditions in the auto parts industry.

Nevertheless, the broker remains positive on its outlook and sees plenty of value on offer with its shares. In addition, Morgans expects Super Retail's shares to offer 6%+ fully franked dividend yields in the near term. The Super Retail share price is trading at $15.34 today.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Super Retail Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Super Retail Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

These ASX 200 shares could rise 20% to 40%

Analysts think these shares could deliver big returns for investors this year.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares.

Read more »

Two brokers analysing stocks.
Broker Notes

Goldman Sachs says this ASX 200 stock is a buy with 25%+ upside

Let's see why the broker is bullish on this name right now.

Read more »

Happy man holding Australian dollar notes, representing dividends.
Broker Notes

Why this cheap ASX All Ords stock could rise 50% and pay an 11% dividend yield

Goldman Sachs thinks that big returns could be coming for buyers of this stock.

Read more »

Woman using a pen on a digital stock market chart in an office.
Broker Notes

CSL stock: Buy, hold, or sell in 2025?

Let's see what analysts are saying about this blue chip giant at the start of the year.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Goldman Sachs says this ASX 200 stock is a top buy in January

The broker is forecasting some big returns for investors this year.

Read more »

A man working in the stock exchange.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys right now.

Read more »